Teva discontinued propofol in 2010, but will reenter the market because of the drug shortage.
Maker Fresenius has increased its drug production, and the FDA will continue to import Propoven, a similar drug, from overseas.
ASA is working closely with the FDA to mitigate and prevent further drug shortages.
More Articles on Anesthesia:
ASA Backs Independent Payment Advisory Board Repeal
Anesthesia Business Consultants Tackles Medical Necessity Confusion
Anesthesia Business Consultants Announces Partnership With Survey Vitals
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
